Nonreplacement therapy for hemophilia in low-income countries: experience from a prospective study in Ivory Coast
Author:
Publisher
Elsevier BV
Subject
Hematology
Reference13 articles.
1. Impact of novel hemophilia therapies around the world;Ozelo;Res Pract Thromb Haemost,2022
2. Definitions in hemophilia: communication from the SSC of the ISTH;Blanchette;J Thromb Haemost,2014
3. Optimal management of hemophilic arthropathy and hematomas;Lobet;J Blood Med,2014
4. Outcome measures in haemophilia: a systematic review;Boehlen;Eur J Haematol Suppl,2014
5. WFH Guidelines for the Management of Hemophilia, 3rd edition;Srivastava;Haemophilia,2020
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Emicizumab as a Promising Form of Therapy for Type A Hemophilia - AReview of Current Knowledge from Clinical Trials;Current Protein & Peptide Science;2024-11
2. Risk of harm to people with haemophilia from the 2023 WHO Essential Medicines List;The Lancet Haematology;2024-09
3. Health-related quality of life in children with severe hemophilia A on emicizumab prophylaxis;The Egyptian Journal of Haematology;2024-04
4. Nothing short of a revolution: Novel extended half-life factor VIII replacement products and non-replacement agents reshape the treatment landscape in hemophilia A;Blood Reviews;2023-12
5. CORR Insights®: What is the Effect of Bevacizumab on Cartilage and Synovium in a Rabbit Model of Hemophilic Arthropathy?;Clinical Orthopaedics & Related Research;2023-05-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3